peptides Tesamorelin for Visceral Fat: The Targeted Approach to Belly Fat Tesamorelin specifically targets visceral belly fat through growth hormone stimulation
These include biological sex, weight, how much someone has had to drink, and how quickly they have consumed alcohol
Growth hormone therapy can induce insulin resistance, elevate fasting glucose, worsen glycemic control in diabetics or pre-diabetics, increase risk of developing type 2 diabetes with long-term use, and require medication adjustments for individuals with existing diabetes
Provided as two separate vials of defined, high purity lyophilized peptides for parallel or comparative assays, this combination is intended solely for laboratory research use
The patients who see the most meaningful results are those who show up consistently and pair their injections with supportive lifestyle habits
It is not approved for human consumption, medical treatment, or diagnostic application